Starting from 13 June 2016 onwards the transitional rules for submission of PSURs to the National Competent Authorities are no longer applicable. MAHs are now required to submit PSURs directly to the PSUR repository using the eSubmission Gateway. Except PSURs for products under Article 58 of Regulation (EC) No 726/2004, all other PSURs are affected by the direct PSUR repository submission irrespective whether they are for centrally or nationally authorised medicinal products and whether they follow the EU single assessment or purely national PSUR procedure. Details are provided in EMA Announcement on the mandatory use of the PSUR repository. In line with that the Bulgarian Drug Agency announced that they will no longer accept local submission of PSURs. The Romanian National Agency for Medicines and Medical Devices also published press release regarding PSUR submission.
Blog
Related Posts
-
Bulgaria changes the structure of its ethics committees in clinical trials
The Bulgarian Drug Law amendments published on 12-Oct-2018 introduced the …
-
EudraVigilance Go-Live: expecting 22 November 2017
The Announcement of the EMA Management Board earlier in May 2017 confirmed …
-
Type IA variations not required any more for administrative changes to EU QPPV and PSMF
Based on the application of Article 57(2) of Regulation (EC) No 726/2004, …
-
The role of the local contact for pharmacovigilance issues
Following the developments of the pharmacovigilance legislations at EU …
-
Romania: is there a requirement for local pharmacovigilance contact person?
With the amendments in the EU pharmacovigilance framework the Member States …
-
The obligation for local PhV contact person in Bulgaria
With the Bulgarian Drug Law amendments published on 21-Dec-2012 a new obligation …
-
Key amendments to the Bulgarian Drug Law
Although the main legislative act governing the pharma sector in Bulgaria …